PPT-Evaluation of ZOSTAVAX®

Author : myesha-ticknor | Published Date : 2016-12-13

Via the Intradermal Route Using the MicronJet Presented by Brian K Meyer 4 th International Conference on Vaccines and Vaccination Valencia Spain September 2426

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Evaluation of ZOSTAVAX®" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Evaluation of ZOSTAVAX®: Transcript


Via the Intradermal Route Using the MicronJet Presented by Brian K Meyer 4 th International Conference on Vaccines and Vaccination Valencia Spain September 2426 2014 Overview ZOSTAVAX Vaccine Background. gov You can also contact us via our Website at httpwwwcdcgovhealthyy ou th evaluationindexhtm Update 2014. Kenneth McCall, . BSPharm. , . PharmD. Associate Professor | UNE. President | Maine Pharmacy Association. Objectives. Discuss the gap between current rates and Healthy People 2020 goals for vaccinations.. www.dotbu.org. .). LTO Evaluation Process. LTO position must be at . least four (4) months long. .. Principals should meet with the OT prior to the evaluation . to provide an overview of the process and areas of consideration, i.e. classroom management, assessment and evaluation, planning, etc.. Wider evaluation is anything that is relevant to both the . AO1 . and the question being asked that is not your initial . IDA . point, evidence and grounding of it or AO3. .. How important is wider evaluation. Learning objectives. By the end of this presentation, you will be able to:. Explain evaluation design . Describe . the differences between types of evaluation . designs. Identify . the key . elements . Laying the Groundwork Before Your First Evaluation Diana Epstein, Ph.D, CNCS Office of Research and Evaluation Adrienne DiTommaso, MPA, CNCS Office of Research and Evaluation Learning objectives Understand five critical activities for your first grant cycle Program Evaluation Webinar Series Part 1: “Top Roadblocks on the Path to Good Evaluation– And How to Avoid Them” Presented by: Tom Chapel Top Roadblocks on the Path to Good Evaluation– And How to Avoid Them  \n  \r   \n \n \n \r    \r \n \n!"\n# Quick Facts Country: QatarType of Evaluat nrnnnrrn nnQuick Facts Country QatarType of Evaluation Final Date of Evaluation May 2008 Mode of Evaluation IndependentAdministrative Office RO-Beirut Technical Backstopping EMP/ENTERPRI herpes zoster (shingles) through immunisation Herpes zoster (shingles) Herpes zoster is commonly a painful, and sometimes debilitating, medical condition. As many as one in three people will have HOPS. History. Observation. Palpation . Special Tests. Evaluation of the ANKLE. History. MAPPS. M = . Mechanism. of injury. A = . Acute. or chronic. P = . Previous. . history. of injury. P = . Pain. Factors. . Evaluation by the . designer. . Every time the designer makes a key design decision or completes a design milestone, then chosen and competing alternatives should be evaluated using the analysis techniques.. EVALUATION STATUS IN MAURITANIA. By . Mohamed Fadel Ould. Ahmed Yahya. . Deputy. . President. . Nouakchott, 07/28/2011. In accordance with:. Millennium Development Goals (. Part I:Real World Evaluation Approaches . May 16, 2012 . YALE-GRIFFIN PREVENTION RESEARCH CENTER. David L. Katz, MD, MPH. Valentine Yanchou Njike, MD, MPH. Jesse Reynolds, MS. Engage stakeholders . Describe the program .

Download Document

Here is the link to download the presentation.
"Evaluation of ZOSTAVAX®"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents